Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients – topic of research paper in Biological sciences. Download scholarly article PDF and read for free
Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidase - ScienceDirect
Liquid Myozyme Syrup 200 Ml, Packaging Size: 1 Bottle at Rs 26/bottle in Chandigarh
MYOZYME® (ALGLUCOSIDASE ALFA)
Cost related to Pompe disease treatment | Download Table
PDF] Infantile Pompe disease treatment with Myozyme in Chaharmahal and Bakhtiari: A case report | Semantic Scholar
Gene Therapy for Pompe Disease: The Time is now | Human Gene Therapy
Enzyme Replacement Therapy Can Reverse Pathogenic Cascade in Pompe Disease: Molecular Therapy Methods & Clinical Development
PDF] Infantile Pompe disease treatment with Myozyme in Chaharmahal and Bakhtiari: A case report | Semantic Scholar
Malattia di Pompe - Wikipedia
Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice | Journal of Pharmacology and Experimental Therapeutics
Lumizyme (Alglucosidase Alfa) in Pompe Disease | Pompe Disease News
Is the 6MWT still the best endpoint for Pompe disease clinical trials?
MYOZYME® (ALGLUCOSIDASE ALFA)
Trump gives Genzyme rare disease drug a shout-out in speech to Congress - Boston Business Journal
Increased Myozyme Dosing May Help With Classic Infantile Pompe
1,6-epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease | Journal of the American Chemical Society